The challenge of an ageing haemophilic population.
Life expectancy for haemophilia has increased significantly in many countries. This represents a major success of the improved safety of therapeutic materials to treat haemophilia and of improved quality of care. This improved longevity will generate a population of older individuals with haemophilia with complex medical problems associated with age and managing such clinical issues is likely to be challenging.
Dolan
G
G
Nottingham University Hospitals, Nottingham, UK. gerry.dolan@nottingham.ac.uk
D000375:Aging; D050197:Atherosclerosis / Q000150:complications; D002318:Cardiovascular Diseases / Q000150:complications* / Q000453:epidemiology; D015897:Comorbidity; D005260:Female; D006467:Hemophilia A / Q000150:complications* / Q000453:epidemiology / Q000628:therapy; D006801:Humans; D008017:Life Expectancy; D008297:Male; D009140:Musculoskeletal Diseases / Q000150:complications; D017202:Myocardial Ischemia / Q000150:complications; D009369:Neoplasms / Q000150:complications*; D012307:Risk Factors